Globus Medical, Inc. (GMED) has a MoatMap StockRank of 94/100 based on Quality (78/100), Value (45/100), and Momentum (59/100) factor scores. The current signal is STRONG BUY. Globus Medical is a high-quality medical device company with a strong moat in robotic surgery and spinal implants, boasting an excellent quality score of 78. However, it lacks a direct macro tailwind from our 18-month themes, making it a high-quality watch-list name rather than an immediate buy.
Globus Medical, Inc. is a medical device company focused on musculoskeletal health, designing, developing, and marketing implants, instruments, and robotic navigation systems for spinal and orthopedic surgeries. Known for rapid innovation and strong R&D, it offers a comprehensive portfolio of solutions, including advanced robotic assistance systems. Its focus on challenging surgical cases and proprietary technologies provides a competitive edge in a specialized market.
| Price | $79.46 |
| Market Cap | $11.2B |
| P/E (TTM) | 18.69 |
| P/E (Forward) | 15.53 |
| Price/Book | 2.29 |
| Return on Equity | 13.3% |
| Return on Invested Capital | 11.2% |
| Debt/Equity | 2.45 |
| Gross Margin | 68.5% |
| Operating Margin | 21.3% |
| Revenue Growth | 27.0% |
| Free Cash Flow | $341M |
Globus Medical, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).